ABBV has been in the news 553% more than usual
Aug 01, 2025, 8:31 PM
7.79%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie Inc. reported Q2 2025 sales of $15.42 billion, surpassing expectations, but its adjusted earnings of $2.97 fell short of the consensus of $3.23. Additionally, President Trump has urged 17 pharmaceutical companies, including AbbVie, to reduce U.S. drug prices to "most favored nation" levels by September 29.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.